Top Markets
Coin of the day
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Classificação em ações #39944
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Preço da ação
$0.00366968
Última sincronização: 2024-07-23
Valor de mercado
$291.42K
Variação (1 dia)
-0.81%
Variação (1 ano)
0.00%
País
US
Negociar Bioasis Technologies Inc. (BTI)

Categoria

Preço BTI com a capitalização de mercado de B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Capitalização de mercado de Bioasis Technologies Inc.(BTI)
Valor de mercado: $291.42K
Em August 2026, Bioasis Technologies Inc. tem uma capitalização de mercado de $291.42K. Isso faz com que Bioasis Technologies Inc. seja a 39944th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Bioasis Technologies Inc. de 2008 a 2026
BTI comparado com o topo de 5 mais populares stocks
Preço para BTI Ativo B Capitalização de mercado de B Resultados
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
$2.854T +979,445,505.37%